Stocktoria

Theravance Biopharma, Inc. TBPH

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-05-16 · LEI

Theravance Biopharma, Inc. statistics & valuation

Market cap$908.9M
P / E8.6×
P / S8.5×
P / B3.1×
Net margin98.5%
Return on equity35.7%
Return on capital-0.8%
Graham number -3.4%$16.34

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($16.34); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-391.90% -1855.00% -357.00% -322.10% -386.90% -360.60% 1698.50% -96.10% -87.60% 98.50% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-371.00% -1690.60% -395.50% -343.10% -414.20% -466.10% -179.10% -97.60% -72.90% -3.40% 2016201720182019202020212022202320242025
Return on equity (%)
-54.40% -247.80% 197.40% -25.90% -32.10% 35.70% 2016201720182019202020212022202320242025
Shares outstanding
52.8M 54.4M 55.7M 57.0M 64.3M 74.4M 73.6M 55.3M 49.5M 51.5M 2016201720182019202020212022202320242025
Net debt ($)
$134.8M $76.3M $397.0M $537.7M $526.4M -$39.5M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-29.80% -64.70% -38.50% -57.80% -59.30% -53.20% 143.60% -14.40% -15.90% 21.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-207.90% 2016201720182019202020212022202320242025
Debt / equity (×)
1.94× 0.00× 2016201720182019202020212022202320242025
EPS ($)
-$4.25 -$4.46 -$2.87 $11.85 -$1.00 -$1.15 $2.06 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-3.4%-72.9%-97.6%-179.1%-466.1%-414.2%-343.1%-395.5%-1690.6%-371.0%
Net margin98.5%-87.6%-96.1%1698.5%-360.6%-386.9%-322.1%-357.0%-1855.0%-391.9%
FCF margin—————————-207.9%
Return on assets21.8%-15.9%-14.4%143.6%-53.2%-59.3%-57.8%-38.5%-64.7%-29.8%
Return on equity35.7%-32.1%-25.9%197.4%58.9%91.5%105.6%417.8%-247.8%-54.4%
Debt / equity——0.00×—-1.82×-2.04×-2.03×-8.81×1.94×—
Current ratio10.935.025.3912.314.263.183.035.416.0510.73

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.